Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Farminveste SGPSXLIS:MLFMV 63 Return-on-Tangible-Equity is 60.78% as of Dec. 2025, which is 86% below its 10-year median of 435.68. GuruFocus rates XLIS:MLFMV with a GF Score™ of 63/100 and a GF Value™ of €1.64 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 112 Medical Distribution companies, Farminveste SGPS ranks better than 88.39% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Farminveste SGPS's annualized net income for the quarter that ended in Dec. 2025 was €21.9 Mil. Farminveste SGPS's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €36.0 Mil. Therefore, Farminveste SGPS's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 60.78%.
The historical rank and industry rank for Farminveste SGPS's Return-on-Tangible-Equity or its related term are showing as below:
XLIS:MLFMV'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 365.72 Med: 435.68 Max: 435.68
Current: 365.72
During the past 11 years, Farminveste SGPS's highest Return-on-Tangible-Equity was 435.68%. The lowest was 365.72%. And the median was 435.68%.
XLIS:MLFMV's Return-on-Tangible-Equity is ranked better than 88.39% of 112
companies
in the Medical Distribution industry
Industry Median: 8.755
vs XLIS:MLFMV: 365.72
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Farminveste SGPS Return-on-Tangible-Equity Related Terms
Farminveste SGPS Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Farminveste SGPS's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XLIS:MLFMV vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Farminveste SGPS's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Farminveste SGPS Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Farminveste SGPS's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Farminveste SGPS's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 60.78% mean?
Farminveste SGPS (XLIS:MLFMV) has a Return-on-Tangible-Equity of 60.78% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Farminveste SGPS and its competitors. This is 86% below median its historical median of 435.68. Over the past decade, Farminveste SGPS's Return-on-Tangible-Equity has ranged from 365.72 to 435.68. According to the industry distribution chart, Farminveste SGPS ranks #13 out of 112 companies in the Medical Distribution industry, placing it in the top 11.6%.
Is Farminveste SGPS's Return-on-Tangible-Equity too high?
Farminveste SGPS's current Return-on-Tangible-Equity of 60.78% is 86% below median its 10-year median of 435.68. Over the past 10 years, this metric has ranged from a low of 365.72 to a high of 435.68. The Medical Distribution industry median Return-on-Tangible-Equity is 8.76. Farminveste SGPS's value of 60.78% is 594.2% above this industry median. Based on the distribution chart, Farminveste SGPS ranks #13 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Farminveste SGPS has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Farminveste SGPS's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Farminveste SGPS ranks #13 out of 112 companies for Return-on-Tangible-Equity. This places Farminveste SGPS in the top 12% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 8.76. Farminveste SGPS's value of 60.78% is 594.2% above this benchmark. Historically, Farminveste SGPS's own Return-on-Tangible-Equity has ranged from 365.72 to 435.68 over the past decade. While the company's 10-year median is 435.68 vs. the industry median of 8.76, Farminveste SGPS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.76, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Farminveste SGPS's current Return-on-Tangible-Equity of 60.78% is 594.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Farminveste SGPS and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farminveste SGPS's current Return-on-Tangible-Equity is 60.78%, which is 86% below median its own 10-year median of 435.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farminveste SGPS stock overvalued right now?
Based on GuruFocus' analysis, Farminveste SGPS (XLIS:MLFMV) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.64, compared to a current price of €5.00 — trading 204.9% above its estimated fair value. The current Return-on-Tangible-Equity is 60.78%, which is 86% below median its 10-year median of 435.68 and 594.2% above the Medical Distribution industry median of 8.76. Farminveste SGPS's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Farminveste SGPS (XLIS:MLFMV), the current Return-on-Tangible-Equity is 60.78% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Farminveste SGPS (XLIS:MLFMV) Overvalued in 2026?
Based on GuruFocus' analysis, Farminveste SGPS stock appears to be overvalued.
The current stock price of €5.00 is trading 204.9% above its estimated GF Value™ of €1.64.
GuruFocus considers Farminveste SGPS to be Significantly Overvalued.
Key valuation signals for XLIS:MLFMV:
Return-on-Tangible-Equity: 60.78% (86% below median its 10-year median of 435.68)
GF Value™: €1.64 vs. price of €5.00 (204.9% above fair value)
Industry Position: 594.2% above the Medical Distribution median (#13 of 112)
No single metric tells the full story. See the XLIS:MLFMV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Farminveste SGPS SA is a holding company and its subsidiaries are active in the business of pharmacies, pharmaceutical distribution, information systems, health care, real estate, market intelligence and other services.
63GF Score
Get the complete analysis for XLIS:MLFMV
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XLIS:MLFMV has been successfully added to your 
